.It is actually an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bica...
.Atea Pharmaceuticals' antiviral has fallen short an additional COVID-19 test, yet the biotech still...
.Neurocrine Biosciences' schizophrenia system pivot has actually neglected. The biotech was actually...
.Sanofi has made an overdue entrance to the radioligand celebration, paying one hundred thousand eur...
.After F2G's 1st attempt to acquire a new training class of antifungal to market was actually thwart...
.Moderna has actually promised to reduce R&D spending by $1.1 billion by 2027. The selection to s...
.Just 4 months after Sanofi bet $80 million in beforehand money on Fulcrum Therapies' losmapimod, th...
.Cancer firm Oncternal Therapeutics is actually folding all its clinical trials and laying off worke...
.Roche is actually holding out hopes that its own injectable being overweight possibility might even...
.Novo Nordisk has actually raised the lid on a stage 1 trial of its own oral amylin and also GLP-1 r...